71 related articles for article (PubMed ID: 11023712)
1. Synergistic interaction of adrenaline and histamine in human platelet aggregation is mediated through activation of phospholipase, map kinase and cyclo-oxygenase pathways.
Shah BH; Lashari I; Rana S; Saeed O; Rasheed H; Arshad Saeed S
Pharmacol Res; 2000 Nov; 42(5):479-83. PubMed ID: 11023712
[TBL] [Abstract][Full Text] [Related]
2. Calcium-dependent synergistic interaction of platelet activating factor and epinephrine in human platelet aggregation.
Saeed SA; Rasheed H
Acta Pharmacol Sin; 2003 Jan; 24(1):31-6. PubMed ID: 12511226
[TBL] [Abstract][Full Text] [Related]
3. Molecular mechanisms involved in human platelet aggregation by synergistic interaction of platelet-activating factor and 5-hydroxytryptamine.
Shah BH; Rasheed H; Rahman IH; Shariff AH; Khan FL; Rahman HB; Hanif S; Saeed SA
Exp Mol Med; 2001 Dec; 33(4):226-33. PubMed ID: 11795484
[TBL] [Abstract][Full Text] [Related]
4. Co-activation of Gi and Gq proteins exerts synergistic effect on human platelet aggregation through activation of phospholipase C and Ca2+ signalling pathways.
Shah BH; Siddiqui A; Qureshi KA; Khan M; Rafi S; Ujan VA; Yakoob MY; Rasheed H; Saeed SA
Exp Mol Med; 1999 Mar; 31(1):42-6. PubMed ID: 10231022
[TBL] [Abstract][Full Text] [Related]
5. Synergism interaction between arachidonic acid by 5-hydroxytryptamine in human platelet aggregation is mediated through multiple signalling pathways.
Saeed SA; Rasheed H; Gilani AU
Acta Pharmacol Sin; 2003 Oct; 24(10):958-64. PubMed ID: 14531936
[TBL] [Abstract][Full Text] [Related]
6. Second messengers in platelet aggregation evoked by serotonin and A23187, a calcium ionophore.
Connor JD; Rasheed H; Gilani AH; Cheema M; Rizvi Z; Saeed SA
Life Sci; 2001 Oct; 69(23):2759-64. PubMed ID: 11720080
[TBL] [Abstract][Full Text] [Related]
7. Synergistic interaction of epinephrine and calcium ionophore in platelet aggregation.
Butt IF; Saeed SA; Waqar SN; Aslam M
J Ayub Med Coll Abbottabad; 2005; 17(2):1-5. PubMed ID: 16092638
[TBL] [Abstract][Full Text] [Related]
8. Investigation of cyclooxygenase and signaling pathways involved in human platelet aggregation mediated by synergistic interaction of various agonists.
Khan N; Farooq AD; Sadek B
Drug Des Devel Ther; 2015; 9():3497-506. PubMed ID: 26185418
[TBL] [Abstract][Full Text] [Related]
9. Signaling mechanisms mediated by G-protein coupled receptors in human platelets.
Saeed SA; Rasheed H; Fecto FA; Achakzai MI; Ali R; Connor JD; Gilani AU
Acta Pharmacol Sin; 2004 Jul; 25(7):887-92. PubMed ID: 15210061
[TBL] [Abstract][Full Text] [Related]
10. Involvement of thromboxane A2 and tyrosine kinase in the synergistic interaction of platelet activating factor and calcium ionophore A23187 in human platelet aggregation.
Rasheed H; Saeed SA
Exp Mol Med; 2004 Jun; 36(3):220-5. PubMed ID: 15272233
[TBL] [Abstract][Full Text] [Related]
11. Protein kinase C inhibitor, chelerythrine, potentiates the adrenaline-mediated aggregation of human platelets through calcium influx.
Shah BH; Shamim G; Khan S; Saeed SA
Biochem Mol Biol Int; 1996 May; 38(6):1135-41. PubMed ID: 8739035
[TBL] [Abstract][Full Text] [Related]
12. Dual effects of nimesulide, a COX-2 inhibitor, in human platelets.
Saeed SA; Afzal MN; Shah BH
Life Sci; 1998; 63(20):1835-41. PubMed ID: 9820127
[TBL] [Abstract][Full Text] [Related]
13. The phospholipase C inhibitor U73122 inhibits phorbol ester-induced platelet activation.
Lockhart LK; McNicol A
J Pharmacol Exp Ther; 1999 May; 289(2):721-8. PubMed ID: 10215645
[TBL] [Abstract][Full Text] [Related]
14. Identifying pathways involved in leptin-dependent aggregation of human platelets.
Corsonello A; Malara A; De Domenico D; Perticone F; Valenti A; Buemi M; Ientile R; Corica F
Int J Obes Relat Metab Disord; 2004 Aug; 28(8):979-84. PubMed ID: 15211358
[TBL] [Abstract][Full Text] [Related]
15. Antiplatelet activity of Phellinus baummii methanol extract is mediated by cyclic AMP elevation and inhibition of collagen-activated integrin-α(IIb) β₃ and MAP kinase.
Kamruzzaman SM; Endale M; Oh WJ; Park SC; Kim TH; Lee IK; Cho JY; Park HJ; Kim SK; Yun BS; Rhee MH
Phytother Res; 2011 Nov; 25(11):1596-603. PubMed ID: 21394810
[TBL] [Abstract][Full Text] [Related]
16. Phosphatidylinositol 3-kinase inhibitor, wortmannin, inhibits 5-hydroxytryptamine-mediated potentiation of platelet aggregation induced by epinephrine.
Shah BH; Saeed SA
Res Commun Mol Pathol Pharmacol; 1995 Aug; 89(2):157-64. PubMed ID: 8556270
[TBL] [Abstract][Full Text] [Related]
17. Cyclooxygenase--independent pathway of phospholipase activation in carrageenan--induced platelet aggregation.
Yeh HI; Chen IJ; Teng CM
Thromb Res; 1987 Jan; 45(1):39-49. PubMed ID: 3105112
[TBL] [Abstract][Full Text] [Related]
18. Comparison of the effects of carvedilol, propranolol, and verapamil on in vitro platelet function in healthy volunteers.
Gasser JA; Betterridge DJ
J Cardiovasc Pharmacol; 1991; 18 Suppl 4():S29-34. PubMed ID: 1721976
[TBL] [Abstract][Full Text] [Related]
19. Inhibition of phospholipase C-independent exocytotic responses in rat peritoneal mast cells by U73122.
Gloyna W; Schmitz F; Seebeck J
Regul Pept; 2005 Feb; 125(1-3):179-84. PubMed ID: 15582730
[TBL] [Abstract][Full Text] [Related]
20. Endothelial cells play an important role in the antiaggregatory effect of nitric oxide.
Klinge JM; Topf HG; Trusen B; Rauh M; Rascher W; Dötsch J
Crit Care Med; 2003 Jul; 31(7):2010-4. PubMed ID: 12847397
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
